The Experts below are selected from a list of 375 Experts worldwide ranked by ideXlab platform

Kiyoyuki Yamada - One of the best experts on this subject based on the ideXlab platform.

Makoto Ojika - One of the best experts on this subject based on the ideXlab platform.

Hideo Kigoshi - One of the best experts on this subject based on the ideXlab platform.

Hendrik Luesch - One of the best experts on this subject based on the ideXlab platform.

  • The Cyanobacterial Origin of Potent Anticancer Agents Originally Isolated from Sea Hares
    Current Medicinal Chemistry, 2002
    Co-Authors: Hendrik Luesch, Gilles H. Goetz, F. David Horgen
    Abstract:

    It is increasingly evident that the true biological origin of many metabolites originally isolated from certain marine macroorganisms is cyanobacterial. For example, several dolastatins, potent cytotoxic compounds originally derived from the sea hare Dolabella auricularia, have now been isolated from marine cyanobacteria of the genera Lyngbya and Symploca. This review discusses the isolation of dolastatins and close structural analogues from cyanobacteria. Biosynthetic signatures of metabolites isolated from sea hares, but which are most probably cyanobacterial in origin, are also presented. Finally, some more complex ecology involving movement of cyanobacterial metabolites through the marine food web is presented.

  • isolation of dolastatin 10 from the marine cyanobacterium symploca species vp642 and total stereochemistry and biological evaluation of its analogue symplostatin 1
    Journal of Natural Products, 2001
    Co-Authors: Hendrik Luesch, Susan L Mooberry, Richard E. Moore, Valerie J. Paul, Thomas H Corbett
    Abstract:

    The potent antitumor agent dolastatin 10 (1) was originally isolated from the sea hare Dolabella auricularia, and we now report its isolation from the marine cyanobacterium Symploca sp. VP642 from Palau. The chemically related analogue symplostatin 1 (2) has been reisolated from Guamanian and Hawaiian varieties of S. hydnoides and its total stereochemistry completed by determining the N,N-dimethylisoleucine unit to be l. Symplostatin 1 (2), like dolastatin 10 (1), is a potent microtubule inhibitor. The antitumor activity of 2 was assessed in vivo against several murine tumors. Symplostatin 1 (2) was effective against a drug-insensitive mammary tumor and a drug-insensitive colon tumor; however, it was only slightly effective against two MDR tumors.

  • isolation structure determination and biological activity of lyngbyabellin a from the marine cyanobacterium lyngbya majuscula
    Journal of Natural Products, 2000
    Co-Authors: Hendrik Luesch, Richard E. Moore, Wesley Y. Yoshida, Valerie J. Paul, Susan L Mooberry
    Abstract:

    Lyngbyabellin A (1), a significantly cytotoxic compound with unusual structural features, was isolated from a Guamanian strain of the marine cyanobacterium Lyngbya majuscula. This novel peptolide is structurally related to dolabellin (2) in that both depsipeptides bear a dichlorinated β-hydroxy acid and two functionalized thiazole carboxylic acid units. Its gross structure has been elucidated by spectral analysis, including 2D NMR techniques. The absolute stereochemistry of 1 was determined by chiral HPLC analysis of hydrolysis products and by characterization of the degradation products methyl 7,7-dichloro-3-hydroxy-2,2-dimethyloctanoate (3) and the corresponding acid 4. The total structure was further supported by molecular modeling studies. The isolation of 1 from L. majuscula once more supports the proposal that many compounds originally isolated from the sea hare Dolabella auricularia are of cyanobacterial origin. Lyngbyabellin A (1) was shown to be a potent disrupter of the cellular microfilament ne...

  • symplostatin 2 a dolastatin 13 analogue from the marine cyanobacterium symploca hydnoides
    Journal of Natural Products, 1999
    Co-Authors: Hendrik Luesch, Wesley Y. Yoshida, Richard E. Moore, Valerie J. Paul
    Abstract:

    An analogue of dolastatin 13 (2) has been isolated from a marine cyanobacterium, Symploca hydnoides, collected near Guam. This new cyclic depsipeptide contains a l-methionine sulfoxide residue; however, the sulfoxide exists as both R- and S-forms, resulting in the doubling of several signals in the 1H and 13C NMR spectra. Structure elucidation required extensive application of 2-D NMR techniques such as COSY, HMQC, HMBC, and ROESY. The trivial name symplostatin 2 (1) has been assigned to the new metabolite and its isolation from S. hydnoides further supports the proposal that many compounds originally isolated from the sea hare Dolabella auricularia are most probably of cyanobacterial origin.

  • symplostatin 1 a dolastatin 10 analogue from the marine cyanobacterium symploca hydnoides
    Journal of Natural Products, 1998
    Co-Authors: Hendrik Luesch, Susan L Mooberry, Thomas H Corbett, Wesley Y. Yoshida, Richard E. Moore, Valerie J. Paul, Fred Valeriote
    Abstract:

    A new solid tumor selective cytotoxic analogue of dolastatin 10 (1) has been isolated from the marine cyanobacterium Symploca hydnoides, collected near Guam. This metabolite has been assigned the trivial name symplostatin 1 (2). This discovery supports the proposal that many compounds isolated from the seahare Dolabella auricularia, the original source of the dolastatins, are of dietary origin.

Kiyotake Suenaga - One of the best experts on this subject based on the ideXlab platform.